ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 317 filers reported holding ROYALTY PHARMA PLC in Q2 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.4%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alaska Permanent Fund Corp | 412,716 | $12,686,890 | 0.25% |
| TWINBEECH CAPITAL LP | 409,709 | $12,594,455 | 0.25% |
| Formidable Asset Management, LLC | 36,524 | $1,123 | 0.24% |
| US FINANCIAL ADVISORS, LLC | 18,449 | $567,123 | 0.24% |
| HORIZON KINETICS ASSET MANAGEMENT LLC | 333,669 | $10,256,985 | 0.22% |
| MRP Capital Investments, LLC | 7,200 | $221,328 | 0.22% |
| Dynamic Technology Lab Private Ltd | 55,471 | $1,705 | 0.22% |
| DUALITY ADVISERS, LP | 53,603 | $1,647,756 | 0.21% |
| Machina Capital S.A.S. | 11,011 | $338,478 | 0.19% |
| Versor Investments LP | 33,813 | $1,039,412 | 0.18% |
| PHILADELPHIA TRUST CO | 58,095 | $1,786 | 0.17% |
| Jackson Creek Investment Advisors LLC | 13,359 | $411 | 0.16% |
| SEVEN EIGHT CAPITAL, LP | 31,904 | $980,729 | 0.16% |
| Bridgefront Capital, LLC | 9,419 | $289,540 | 0.16% |
| Y-Intercept (Hong Kong) Ltd | 48,011 | $1,475,858 | 0.16% |
| AFFINITY INVESTMENT ADVISORS, LLC | 8,514 | $261,720 | 0.15% |
| PDT Partners, LLC | 34,422 | $1,058,132 | 0.15% |
| AIGEN INVESTMENT MANAGEMENT, LP | 32,048 | $985,156 | 0.15% |
| MORGAN STANLEY | 47,429,861 | $1,457,994,028 | 0.14% |
| ASB Consultores, LLC | 9,572 | $294,243 | 0.14% |
External links
This page lists ROYALTY PHARMA PLC's shareholders in Q2 2023. To view ROYALTY PHARMA PLC's shareholder history, click here.